Viewing Study NCT01261793


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-02-04 @ 12:18 PM
Study NCT ID: NCT01261793
Status: COMPLETED
Last Update Posted: 2020-12-04
First Post: 2010-12-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
Sponsor: UCB Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lupus View
None Monoclonal antibody View
None B-Cell immunotherapy View
None Epratuzumab View